AFP and hepatocellular carcinoma: The obviously increase of AUC of LC-SPIK compared to AFP (0.84 vs. 0.72), especially in detecting early-stage HCC (0.83 vs. 0.65), is significant because AFP has demonstrated poor performance as a biomarker for HCC in non-viral cirrhosis patients, particularly for early-stage HCC [71].